Overview
Ireland digital validation firm's Q1 revenue rose 22% yr/yr, slightly beating analyst expectations
Company posted a net loss of C$3.9 mln, reversing a profit from a year earlier
Gross profit grew 28% yr/yr and gross margin improved to 78%
Outlook
Company says sales pipeline remains strong and trend toward digitalization continues
Company expects to benefit from sustained growth in life sciences industry digital validation
Company reports positive customer feedback on recent product developments, including embedded AI capabilities
Result Drivers
DIGITALIZATION DEMAND - Co said growth was driven by life sciences industry shift toward digital validation
NEW CUSTOMER WINS - Co cited new contracts with biopharma and pharmaceutical manufacturers as contributing to growth
PRODUCT INNOVATION - Co highlighted positive customer feedback on embedded AI capabilities and recent product developments
Company press release: ID:nGNX76qykp
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
C$18 mln
C$17.95 mln (5 Analysts)
Q1 EPS
-C$0.04
Q1 Gross Margin
78.00%
Q1 Basic EPS
-C$0.04
Q1 Gross Profit
C$14 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for Kneat.com Inc is C$6.00, about 13.9% above its May 12 closing price of C$5.27
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)